Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
The process of introducing a new medication to the market, starting from initial development to the final launch, is both time-intensive and heavily regulated, often spanning over a decade or more. Achieving success in this endeavor hinges on the timely availability of precise analytical data, which is essential for making informed decisions during the early stages of development and reducing the likelihood of setbacks later on. Modern drug development primarily follows a systematic approach, with the crucial first step usually being the identification of a biological target to concentrate efforts on. This target identification demands a comprehensive understanding of the characteristics of the candidates, enabling swift and reliable identification of the most promising options. After establishing a biological target, the next significant hurdle is identifying the most advantageous lead molecules, which entails discovering potential drug candidates—these may include small organic compounds or biological constructs with therapeutic capabilities. Thus, the entire journey from concept to market is a complex interplay of scientific insight and strategic decision-making.
Description
Geneious Prime enhances access to bioinformatics by converting raw datasets into intuitive visual representations that facilitate sequence analysis in a user-friendly manner. It offers straightforward sequence assembly along with the convenient editing of contigs. Users benefit from automatic gene prediction, motif identification, translation, and variant calling through its annotation features. It also allows for the genotyping of microsatellite traces using automated ladder fitting and peak calling, producing comprehensive tables of alleles. The platform showcases beautifully designed visualizations of annotated genomes and assemblies, presented in a customizable sequence view that enhances user experience. Furthermore, it supports powerful analyses of SNP variants, simplifies RNA-Seq expression evaluations, and assists in amplicon metagenomics. Users can also design and test PCR and sequencing primers while developing their own searchable primer database. Additionally, Geneious Biologics provides a versatile, scalable, and secure solution to optimize workflows for antibody analysis, enabling the creation of high-quality libraries and the selection of the most suitable therapeutic candidates. This integration of tools fosters greater efficiency and innovation in biological research.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
$1,280 per year
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Bruker
Founded
1960
Country
United States
Website
www.bruker.com/en/applications/pharma/drug-discovery.html
Vendor Details
Company Name
Geneious
Founded
2003
Country
New Zealand
Website
www.geneious.com